US Patent Issued to SENECA THERAPEUTICS, THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK on Dec. 23 for "Second generation Seneca Valley virus oncolytic therapy: compositions and methods thereof" (New York, Pennsylvania, New Jersey Inventors)

ALEXANDRIA, Va., Dec. 23 -- United States Patent no. 12,502,414, issued on Dec. 23, was assigned to SENECA THERAPEUTICS INC. (Blue Bell, Pa.) and THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK (New York).

"Second generation Seneca Valley virus oncolytic therapy: compositions and methods thereof" was invented by Vincent R. Racaniello (Scotch Plains, N.J.), Amy B. Rosenfeld (New York) and Paul L. Hallenbeck (Blue Bell, Pa.).

According to the abstract* released by the U.S. Patent & Trademark Office: "Provided herein are compositions and methods of using Seneca Valley Virus (SVV) or a derivative thereof and an interferon type I (IFN-I) inhibiting agent comprising an mTOR inhibitor for treating a cancer in a subject. The disclosed...